Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2025-12-24 @ 4:16 PM
NCT ID:
NCT07096466
Eligibility Criteria:
Inclusion Criteria:
* Written informed consent to participate in the study
* Willingness to actively participate in the study and to come to the scheduled visits
* Female and/or male
* From 18 to 65 years of age
* Healthy skin in the test area
* Uniform skin color in the test area
* Fitzpatrick I-III
* Able to read and follow directions as outlined in the protocol
Exclusion Criteria:
* Female subjects: Pregnancy or lactation
* Drug addicts, alcoholics
* AIDS, HIV-positive or infectious hepatitis
* Conditions which exclude a participation or might influence the test reaction/evaluation
* Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
* Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years
* Insulin-dependent diabetes mellitus (type 1 and 2)
* Documented allergies to cosmetic products and/or ingredients,
* Documented allergies to plaster systems or tape adhesives
* Active skin disease at the test area like acute dermatitis, that requires actual topical medication on the test area and/or systemic drug treatment according to a physician
* Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation
* All kinds of beard (except a moustache) during the whole study
* Any topical medication at the test area within the last 3 days prior to the start of the study and throughout the entire course of the study
* Topical medication with anti-inflammatories, antihistamines within 1 week prior to the start of the study
* Topical medication with Immuno-suppressive medication within 2 weeks prior to the start of the study
* Systemic (oral) medication with Antibiotic (except penicillin) or anti-inflammatory steroids within 4 weeks prior to the start of the study and throughout the entire course of the study
* Systemic (oral) medication with anti-inflammatory non-steroids within 2 weeks prior to the start of the study and throughout the entire course of the study
* Phototherapy within 4 weeks prior to the start of the study and throughout the entire course of the study
* Systemic (oral) medication with retinoids within 6 months prior to the start of the study and throughout the entire course of the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07096466
Study Brief:
Protocol Section:
NCT07096466